Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
8
67%
Ph phase_3
1
8%
Ph phase_1
1
8%
Ph phase_4
2
17%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(5)
Terminated(3)
Other(2)

Detailed Status

Completed5
Not yet recruiting2
Withdrawn2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 31 (8.3%)
Phase 42 (16.7%)
N/A8 (66.7%)

Trials by Status

not_yet_recruiting217%
terminated18%
withdrawn217%
completed542%
unknown217%

Recent Activity

0 active trials
Showing 5 of 12
not_yet_recruitingnot_applicable

Retrograde Intrarenal Surgery Versus Extracorporeal Shockwave Lithotripsy

NCT07510178
not_yet_recruitingnot_applicable

Energy Ramping Versus Fixed Dose ESWL

NCT07334236
completednot_applicable

The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones

NCT06814834
completednot_applicable

Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy

NCT05725122
completednot_applicable

Extracorporeal Shock Wave Lithotripsy for Treatment of Large Pediatric Renal Pelvic Stone Burden More Than 2 cm

NCT05293613
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07510178Not Applicable

Retrograde Intrarenal Surgery Versus Extracorporeal Shockwave Lithotripsy

Not Yet Recruiting
NCT07334236Not Applicable

Energy Ramping Versus Fixed Dose ESWL

Not Yet Recruiting
NCT06814834Not Applicable

The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones

Completed
NCT05725122Not Applicable

Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy

Completed
NCT05293613Not Applicable

Extracorporeal Shock Wave Lithotripsy for Treatment of Large Pediatric Renal Pelvic Stone Burden More Than 2 cm

Completed
NCT00133835Phase 1

Comparison of ESWL Alone and ESWL + Endoscopy for Painful Chronic Pancreatitis

Completed
NCT05077007Not Applicable

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

Unknown
NCT04819828Phase 4

Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones

Completed
NCT03714477Not Applicable

A Study to Investigate the Effect of Extracorporeal Shockwave Lithotripsy on Hypertension

Withdrawn
NCT02971475Not Applicable

ESWL Versus ESWL and Endoscopic Treatment

Unknown
NCT01560091Phase 3

Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy

Withdrawn
NCT00042549Phase 4

Lithotripsy for the Treatment of Gallstones

Terminated

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12